Vistin Pharma — AGM Information 2025

Apr 29, 2025

Proposal from the Election Committee in Vistin Pharma ASA for the Annual General Meeting to be held in May 2025

The following constitute the Election Committee of Vistin Pharma ASA:

• · Eivind Devold (Chairman)
• Nils Erling Ødegaard .

The Election Committee has evaluated the work of the Board of Directors and received input from shareholders about the composition of the Board.

Election of Board members

The two-year election period for the following Board members expires at the AGM in 2026, and consequently these board members are not up for election now:

• Øyvin A. Brøymer .
• Bettina Banoun 0
• Kari Krogstad .
• Espen Marcussen .

The following shareholder elected Board member has been elected until AGM in 2025, and is up for election:

Øystein Stray Spetalen .

The Election Committee proposes that Øystein Stray Spetalen is re-elected for a period of 2 years.

If the shareholders approve the proposal from the Election Committee, the Board will consist of the following shareholder elected members:

• Øyvin A Brøymer (Chairman) .
• Bettina Banoun ●
• Kari Krogstad .
• Espen Marcussen 0
• 0 Øystein Stray Spetalen

Observer on the board

Former CEO, Kjell-Erik Nordby was elected as an observer on the board with full speaking rights, but without the right to vote, at the AGM in 2024, for a period of 2 years, expiring at the AGM in 2026.

Election of members for the Election Committee

The two-year election period for the current members of the Election Committee expires at the AGM in 2025.

lt is proposed that the Election Committee is re-elected for a new two-year period and, if the it is propoers approve the proposal, the Election Committee will consist of the following shareholder elected members:

• Eivind Devold (Chairman) .
• Nils Erling Ødegaard .

Remuneration of the Board of Directors and Observer on the Board

The proposal below is based on fee uplifts for the Chairman of the Board and Board members of 6.5% and 10.0%, respectively, from the previous period.

The Board fees are proposed to be the following from AGM held in May 2025 until AGM in 2026:

• Chairman: NOK 490.000 .
• · All other Board Members: NOK 264,000

It is further proposed that Kjell-Erik Nordby will receive a fee equal to the fees of the board members, equivalent to NOK 264.000 from AGM held in May 2025 until AGM in 2026.

Remuneration for the Election Committee and the Remuneration Committee

The Election Committee proposes that the remuneration for the Chairman should be NOK 30,000, and for any other member NOK 25,000, and the members of the Remineration Committee should receive NOK 25 000, for the period from the AGM 2025 to the AGM 2026.

Oslo, 13. March 2025

The Election Committee of Vistin Pharma ASA

Nils Erling Ødegaard

Eivind Devold (Leader)